5-(2-Hydroxyethyl)-2’,3’-di-O-toluoyl-2’-deoxyuridine

• UNSPSC Description:

  5-(2-Hydroxyethyl)-2’,3’-di-O-toluoyl-2’-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

• Target Antigen:

  Nucleoside Antimetabolite/Analog

• Type:

  Oligonucleotides

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/5-2-hydroxyethyl-2-3-di-o-toluoyl-2-deoxyuridine.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC=C(C)C=C1)OC[C@@H]2[C@@H](OC(C3=CC=C(C)C=C3)=O)C[C@H](N4C=C(CCO)C(NC4=O)=O)O2

• Molecular Weight:

  508.52

• References & Citations:

  [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported